Competitive intelligence on 
 small-molecule drugs and 
 the 90,000 global patents 
 covering them 

Start your free trial now

Plans and Pricing

DrugPatentWatch Ultimate Plan Preview

Details for Generic Name: desmopressin acetate

« Back to Dashboard
Desmopressin acetate is the generic ingredient in nine branded drugs marketed by Ferring Pharms Inc, Bedford, Hospira, Sun Pharm Inds Ltd, Teva Pharms Usa, Ferring, Sun Pharm Inds, Bausch And Lomb, Apotex Inc, Sun Pharma Global, Csl Behring, Actavis Labs Fl Inc, Mylan Pharms Inc, and Teva Pharms, and is included in twenty NDAs. There is one patent protecting this compound. Additional information is available in the individual branded drug profile pages.

There are seventeen drug master file entries for desmopressin acetate. Four suppliers are listed for this compound. There is one tentative approval for this compound.

Summary for Generic Name: desmopressin acetate

Drug Master File Entries: see list17
Suppliers: see list4
Therapeutic Class:Hormonal Agents, Stimulant/Replacement/Modifying (Pituitary)
Formulation / Manufacturing:see details

Tentative approvals for DESMOPRESSIN ACETATE

Applicant Application No. Form Dosage
<disabled><disabled>TABLET; ORAL0.1MG
<disabled><disabled>TABLET; ORAL0.2MG

Clinical Trials for: desmopressin acetate

Efficacy and Safety of Desmopressin Melt for the Treatment of Nocturia
Status: Completed Condition: Nocturia

The Effect of Gender on Antidiuresis - Evaluated by Graded Low Dose Desmopressin Infusion
Status: Completed Condition: Gender Difference in V2 Receptor Function in Response to dDAVP Infusion; Nocturia; Nocturnal Enuresis

An Extension Study Investigating the Efficacy and Safety of a Fast-Dissolving ("Melt") Formulation of Desmopressin for the Treatment of Nocturia in Adults
Status: Completed Condition: Nocturia

Desmopressin Response in the Young
Status: Completed Condition: Primary Nocturnal Enuresis

Effect of Aspirin, Hemodilution and Desmopressin on Platelet Dysfunction
Status: Completed Condition: Platelet Dysfunction; Hemodilution; Mild Hypothermia; NSAID; Desmopressin

Comparative Trial to Investigate the Dose-Response of 4 Different Dose Levels of Minirin Melt and Placebo
Status: Completed Condition: Nocturia

Courtesy of
See more clinical trials for this drug
Applicant Tradename Generic Name Dosage NDA Approval Date Type RLD Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Csl Behring
desmopressin acetate
SPRAY, METERED;NASAL020355-001Mar 7, 1994DISCNNo<disabled><disabled>
Ferring Pharms Inc
desmopressin acetate
INJECTABLE;INJECTION018938-002Apr 25, 1995DISCNNo<disabled><disabled>
desmopressin acetate
SPRAY, METERED;NASAL021333-001Sep 16, 2002RXYes<disabled><disabled>
Ferring Pharms Inc
desmopressin acetate
INJECTABLE;INJECTION018938-001Mar 30, 1984RXYes<disabled><disabled>
Sun Pharm Inds Ltd
desmopressin acetate
INJECTABLE;INJECTION091280-001Jan 25, 2013RXNo<disabled><disabled>
This preview shows a limited data set
Subscribe for full access, or try a free trial

Export unavailable in trial.
Subscribe for complete access.

« Back to Dashboard

DrugPatentWatch Archives

You are viewing the current data set
Select a link below to view the archives:

 2000   2001   2002   2003   2004   2005   2006   2007   2008   2009   2010   2011   2012   2013   2014  

For more information try a free trial or see the plan comparison

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors.

Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided information. There is no warranty that the information contained herein is error free. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

Copyright 2002-2015 thinkBiotech LLC
ISSN: 2162-2639

Preferred citation:

Friedman, Y. Location of pharmaceutical innovation: 2000–2009 Nature Reviews Drug Discovery 9, 835–836 (2010).

Connect with Social Media:

Follow DrugPatentWatch on Twitter
Connect with DrugPatentWatch on Linkedin
Drug Patents on LinkedIn